Lippincott ® NursingCenter ® Wolters Kluwer Logo

Emergency Use Authorization for Bamlanivimab in Mild to Moderate COVID-19: Implications for Clinical Nurse Specialist Practice

Join NursingCenter to access all articles

Source:

Clinical Nurse Specialist: The Journal for Advanced Nursing Practice

May/June 2021, Volume 35 Number 3 , p 112 - 115

Earn 1.5 Contact Hours

This article has an associated Continuing Education component.
Cost for CE: $17.95.
Expires June 02, 2023.

Authors

  1. O'Malley, Patricia Anne PhD, APRN-CNS

CE Resources

Nursing Resources

About NursingCenter

 

© 2023 Wolters Kluwer Health, Inc. and/or its subsidiaries. All rights reserved. – Terms & Conditions – Privacy Policy – Disclaimer -- v08.09.00